Range Overview

SGD Pharma announces that its 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format.

SGD Pharma is a leader in glass pharmaceutical packaging for healthcare.

Discover our full collection.

SGD Pharma extends Sterinity molded glass vial platform, with the introduction of amber glass 50ml.

Strengthened value propositions represent the latest step in SGD Pharma’s commitment to continuous improvement 

The leading packaging solution that combines exceptional quality vials designed to suit the most demanding, high-value therapeutic products, alongside tailored expert guidance, and priority technical and regulatory support services. AXpert Type I molded glass vials are subject to our usual online automated inspection as well as additional offline quality control, offering the highest cosmetic quality and minimizing post-filling loss of valuable product.

Through its sustainable, environmental and CSR efforts, SGD Pharma has received a platinum award that positions it in the top 1% of rated companies

Reliable, high-quality glass vials for essential or primary care drugs requiring optimized inert packaging options. AXess supports manufacturers’ ability to remain flexible in a dynamic and challenging pharmaceutical marketplace where optimizing Total Cost of Ownership (TCO) is vital.

Discover all key features and benefits of plastic coating options offered by SGD Pharma

Superior quality vials suitable for the widest range of parenteral drug applications, with a variety of options for customization, from vial design to palletization. AXecure is the de-facto standard solution for parenteral packaging that helps to maximize the value of your therapeutic products without compromising your bottom line.

Highly complex biologics and other speciality drugs are representing an increasing proportion of the pharmaceutical market, and their pivotal role in this market has been challenging glass primary packaging producers year after year. Together with this, trends such as more personalized treatments in place of blockbuster drugs, increasing regulatory quality and compliance requirements, and a move towards more self-medication, are changing the way drugs are administered and therefore manufactured. Pharmaceutical companies are requested to be flexible, to reduce time-to-market, increasing quality and reducing costs. To meet the needs of the market and address these challenges, primary packaging design is moving towards ready-to-use (RTU) components as a preferred solution.
https://www.sgd-pharma.com/whitepapers/increasing-flexibility-pharmaceutical-packaging-aseptic-filling

An evaluation of current and future child-resistant packaging trends in the pharmaceutical industry.
Despite a reduction in cases in recent years, unintentional child poisoning remains a considerable risk in the home, with over-the-counter and prescription medicines presenting the greatest risk. Patients and stakeholders are calling upon the pharmaceutical industry to recognize the importance of child-resistant closures (CRCs) in medical packaging that is effective at preventing young children opening medication, while remaining accessible to senior patients. By partnering with packaging manufacturers that can offer certified child-resistant packaging solutions, pharmaceutical companies can guarantee their products meet relevant regulatory requirements, avoid brand damage and fines through non-compliance, and keep children safe from poisoning.

https://www.sgd-pharma.com/whitepapers/protecting-children-with-child-resistant-packaging

Discover the latest global regulatory updates in the fast-moving CBD industry.
The cannabidiol (CBD) market continues to grow rapidly, with regulations varying across different geographies and undergoing continuous updates. CBD manufacturers must not only navigate the CBD regulatory landscape, but that of cannabis itself, as well as pharmaceutical and food packaging and labelling, making it one of the most complex markets to operate in.

We have updated our white paper to reflect these ongoing developments, now including insights from Croatia, Hungary, Poland, Czech Republic, Bulgaria, Russia, Romania, Macedonia, and Israel.
https://www.sgd-pharma.com/whitepapers/navigating-the-cannabidiol-regulatory-landscape

Discover the latest global regulatory updates in the fast-moving CBD industryThe cannabidiol (CBD) market continues to grow rapidly, with regulations varying across different geographies and undergoing continuous updates. CBD manufacturers must not only navigate the CBD regulatory landscape, but that of cannabis itself, as well as pharmaceutical and food packaging and labelling, making it one of the most complex markets to operate in.

We have updated our white paper to reflect these ongoing developments, now including insights from Croatia, Hungary, Poland, Czech Republic, Bulgaria, Russia, Romania, Macedonia, and Israel.

Download the new white paper for a closer look at:

What CBD is and how it is usedHow CBD is regulated in key countries in Europe, North America, the Middle East, and Latin AmericaImportant updates including the recent European Court of Justice ruling on the legality of CBD in FranceThe vital role of compliant pharmaceutical-grade packaging in relieving regulatory concerns.
https://www.sgd-pharma.com/whitepapers/navigating-the-cannabidiol-regulatory-landscape

Learn how to achieve true flexibility and compliance in aseptic fill/ finish lines.Ready-to-use (RTU) glass containers are enabling Pharma Companies to keep pace with the growing complex biologics and other specialty drugs market. By increasing flexibility, reducing time-to-market and total cost of ownership (TCO), and preserving safety and quality standards of the system, RTU molded glass vials now offer a new choice in aseptic manufacturing processes and technologies. Molded glass brings improved chemical durability and greater mechanical strength, combined with the well-proven secondary packaging platform designed for RTU vials, such as Tray and Nest&Tub.

Take a closer look at:

A review of RTU packaging trendsThe advantages of RTU molded glass vialsThe benefits of an integrated primary and secondary RTU packaging solution.
https://www.sgd-pharma.com/whitepapers/increasing-flexibility-pharmaceutical-packaging-aseptic-filling

Welcome to SGD Pharma, a leader in glass pharmaceutical packaging for healthcare.

Our unique know-how and capabilities deliver innovative and premium quality packaging solutions that meet and exceed international pharmacopoeia requirements. From design to manufacturing, our teams will support you to develop and realize your project.

As a result of the higher volume of injectable glass vials diverted to the supply of COVID-19 vaccines, some pharma companies are facing shortages of containers, particularly amber tubular vials, for pharmaceuticals and biological parenteral products. We’re on hand to meet the urgent needs of drug manufacturers with the immediate availability of our molded glass vials. Get in touch today to ensure continuity of drug supply to market. 

https://www.sgd-pharma.com/type-i-molded-glass-vials

Our world-renowned expertise in Type I molded glass manufacture for pharmaceutical primary packaging places our solutions, and our customers, at the forefront of innovation. We’re committed to developing best-in-class, high quality vials and bottles for the most challenging parenteral drugs. 

SGD Pharma is using its world-class expertise to help match you with the best fitting packaging and services solution based on your unique business and product requirements.

The leading quality packaging solution ideally suited to the most demanding parenteral drug applications.

Discore more: https://www.sgd-pharma.com/parenteral-type-i-offer